COVID-19

Long-term cognitive problems after a novel coronavirus (COVID-19) diagnosis may be a result of fatigue rather than pathological changes in the brain,

Patients experiencing post-acute COVID syndrome (PACS), also known as “long COVID” may have symptoms for at least 12 months after initial

Americans are struggling with the basic decisions required to navigate daily life as the effects of pandemic-related stress continue to take a toll,

The antiviral properties of lactoferrin makes it a great natural supplement that could also be used as an adjunct for respiratory tract infections

The two-dose immunization schedule for COVID-19 mRNA vaccines ultimately stimulates comparable antibody responses in pregnant, lactating, and

The U.S. Food and Drug Administration (FDA) announced on Friday the emergency use authorization of the Pfizer-BioNTech novel coronavirus (COVID-19)

Some viral diseases could possibly contribute to neurodegeneration, according to new research published in the journal Nature Communications.

The

A program offered by the University of California, Los Angeles (UCLA) Health’s intensive care units providing meaningful and compassionate